NEW YORK, July 15, 2021 /PRNewswire/ — Moderna Inc. (NASD:MRNA) will replace Alexion Pharmaceuticals Inc. (NASD:ALXN) in the S&P 500 effective prior to the opening of trading on Wednesday, July 21. AstraZeneca Plc (LSE:AZN; NASD:AZN) is acquiring Alexion Pharmaceuticals in a deal expected to be completed soon pending final closing conditions.
Following is a summary of the changes that will take place prior to the open of trading on the effective date:
|
Effective Date |
Index Name |
Action |
Company… |
Source link
